Right Ventricular Infarction

Area of Science:

• Cardiology
• Cardiovascular Medicine
• Internal Medicine

Background:

• Right ventricular (RV) ischemia is a frequent complication of acute inferior myocardial infarction (MI).
• RV infarction (RVI) identifies a high-risk patient subset with significantly increased mortality (25-30%) compared to those without RVI (~6%).
• Early recognition of RV ischemic dysfunction is critical due to distinct therapeutic strategies compared to left ventricular (LV) failure.

Purpose of the Study:

• To highlight the importance of early recognition and specific management of RV ischemic dysfunction in acute inferior MI.
• To differentiate therapeutic approaches for RV dysfunction from those for LV failure-induced cardiogenic shock.
• To emphasize the benefits of timely reperfusion therapy in patients with RVI.

Main Methods:

• Review of clinical evidence regarding RV ischemia in acute inferior MI.
• Analysis of mortality rates in patients with and without RVI.
• Discussion of management strategies for RV ischemic dysfunction.
• Evaluation of the impact of reperfusion therapy on RV function and clinical outcomes.

Main Results:

• RVI is associated with a substantial increase in mortality in acute inferior MI patients.
• Effective management involves maintaining RV preload, atrioventricular synchrony, inotropic support, and reducing RV afterload.
• Reperfusion therapy, particularly of the right coronary artery, rapidly improves RV ejection fraction and hemodynamic status.
• Successful reperfusion decreases in-hospital mortality and morbidity in patients with RVI.

Conclusions:

• Early identification of RV ischemic dysfunction in inferior MI is vital for appropriate management.
• Specific interventions, including volume loading, inotropic support, and afterload reduction, are key.
• Prompt reperfusion therapy is strongly indicated and leads to improved RV function and reduced mortality.